Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alimta and cyclophosphamide in advanced breast cancer
NCT00190671Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jun 2005
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of pemetrexed in breast cancer, sponsored by Eli Lilly and Company. Started Jun 2005; status: completed.
02
Drugs
pemetrexed
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00190671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00190671.